Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967521 · ClinicalTrials.gov registry record · Phase 3
SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma
A Phase 3 study of Advanced Dedifferentiated Liposarcoma, sponsored by Sarcoma Alliance for Research through Collaboration.
- Active
- Registry status
- Phase 3
- Development phase
- 108
- Enrollment target
- 9
- Study locations
NCT04967521 is a Phase 3 study of Advanced Dedifferentiated Liposarcoma that is active but no longer recruiting, run by Sarcoma Alliance for Research through Collaboration. The registered enrollment target is 108 participants. The trial reports 9 study locations across 9 states.
The verdict
NCT04967521, a Phase 3 study of Advanced Dedifferentiated Liposarcoma, is active but no longer recruiting, sponsored by Sarcoma Alliance for Research through Collaboration.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 108 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a Phase 3 randomized double-blind study of abemaciclib versus placebo. Patients with progression of disease will cross over to open label abemaciclib.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Abemaciclib
Study Locations (9)
Colorado
- University of Colorado Cancer Center, Anschutz Medical Campus - Aurora
Florida
- Mayo Clinic Florida - Jacksonville
Illinois
- Northwestern University - Chicago
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering Cancer Center - New York
North Carolina
- Duke University - Durham
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-11-11 |
| Est. Completion | 2026-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967521
The ClinicalTrials.gov registry entry for NCT04967521 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sarcoma Alliance for Research through Collaboration, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Dedifferentiated Liposarcoma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04967521 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Colorado, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT04967521 about?
NCT04967521 is a clinical study titled "SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma". This is a Phase 3 randomized double-blind study of abemaciclib versus placebo. Patients with progression of disease will cross over to open label abemaciclib.
What is the current status of trial NCT04967521?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 108 participants. The study started on 2021-11-11. Estimated completion is 2026-12.
What conditions does trial NCT04967521 study?
This clinical trial studies the following conditions: Advanced Dedifferentiated Liposarcoma.
What interventions are being tested in trial NCT04967521?
The interventions under investigation include: Placebo (DRUG), Abemaciclib (DRUG).
Who is sponsoring clinical trial NCT04967521?
This trial is sponsored by Sarcoma Alliance for Research through Collaboration, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04967521 being conducted?
This trial has 9 study locations across Colorado, Florida, Illinois, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Dedifferentiated Liposarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.